Template:PDB Gallery/1432

• 1a9u: THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB203580
  1a9u: THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB203580
• 1bl6: THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB216995
  1bl6: THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB216995
• 1bl7: THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB220025
  1bl7: THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB220025
• 1bmk: THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB218655
  1bmk: THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB218655
• 1di9: THE STRUCTURE OF P38 MITOGEN-ACTIVATED PROTEIN KINASE IN COMPLEX WITH 4-[3-METHYLSULFANYLANILINO]-6,7-DIMETHOXYQUINAZOLINE
  1di9: THE STRUCTURE OF P38 MITOGEN-ACTIVATED PROTEIN KINASE IN COMPLEX WITH 4-[3-METHYLSULFANYLANILINO]-6,7-DIMETHOXYQUINAZOLINE
• 1ian: HUMAN P38 MAP KINASE INHIBITOR COMPLEX
  1ian: HUMAN P38 MAP KINASE INHIBITOR COMPLEX
• 1kv1: p38 MAP Kinase in Complex with Inhibitor 1
  1kv1: p38 MAP Kinase in Complex with Inhibitor 1
• 1kv2: Human p38 MAP Kinase in Complex with BIRB 796
  1kv2: Human p38 MAP Kinase in Complex with BIRB 796
• 1lew: CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS NUCLEAR SUBSTRATE MEF2A
  1lew: CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS NUCLEAR SUBSTRATE MEF2A
• 1lez: CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS ACTIVATOR MKK3B
  1lez: CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS ACTIVATOR MKK3B
• 1m7q: Crystal structure of p38 MAP kinase in complex with a dihydroquinazolinone inhibitor
  1m7q: Crystal structure of p38 MAP kinase in complex with a dihydroquinazolinone inhibitor
• 1ouk: The structure of p38 alpha in complex with a pyridinylimidazole inhibitor
  1ouk: The structure of p38 alpha in complex with a pyridinylimidazole inhibitor
• 1ouy: The structure of p38 alpha in complex with a dihydropyrido-pyrimidine inhibitor
  1ouy: The structure of p38 alpha in complex with a dihydropyrido-pyrimidine inhibitor
• 1ove: The structure of p38 alpha in complex with a dihydroquinolinone
  1ove: The structure of p38 alpha in complex with a dihydroquinolinone
• 1oz1: P38 MITOGEN-ACTIVATED KINASE IN COMPLEX WITH 4-AZAINDOLE INHIBITOR
  1oz1: P38 MITOGEN-ACTIVATED KINASE IN COMPLEX WITH 4-AZAINDOLE INHIBITOR
• 1p38: THE STRUCTURE OF THE MAP KINASE P38 AT 2.1 ANGSTOMS RESOLUTION
  1p38: THE STRUCTURE OF THE MAP KINASE P38 AT 2.1 ANGSTOMS RESOLUTION
• 1r39: THE STRUCTURE OF P38ALPHA
  1r39: THE STRUCTURE OF P38ALPHA
• 1r3c: THE STRUCTURE OF P38ALPHA C162S MUTANT
  1r3c: THE STRUCTURE OF P38ALPHA C162S MUTANT
• 1w7h: P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
  1w7h: P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
• 1w82: P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
  1w82: P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
• 1w83: P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
  1w83: P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
• 1w84: P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
  1w84: P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
• 1wbn: FRAGMENT BASED P38 INHIBITORS
  1wbn: FRAGMENT BASED P38 INHIBITORS
• 1wbo: FRAGMENT BASED P38 INHIBITORS
  1wbo: FRAGMENT BASED P38 INHIBITORS
• 1wbs: IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.
  1wbs: IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.
• 1wbt: IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.
  1wbt: IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.
• 1wbv: IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.
  1wbv: IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.
• 1wbw: IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.
  1wbw: IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.
• 1wfc: STRUCTURE OF APO, UNPHOSPHORYLATED, P38 MITOGEN ACTIVATED PROTEIN KINASE P38 (P38 MAP KINASE) THE MAMMALIAN HOMOLOGUE OF THE YEAST HOG1 PROTEIN
  1wfc: STRUCTURE OF APO, UNPHOSPHORYLATED, P38 MITOGEN ACTIVATED PROTEIN KINASE P38 (P38 MAP KINASE) THE MAMMALIAN HOMOLOGUE OF THE YEAST HOG1 PROTEIN
• 1yqj: Crystal Structure of p38 Alpha in Complex with a Selective Pyridazine Inhibitor
  1yqj: Crystal Structure of p38 Alpha in Complex with a Selective Pyridazine Inhibitor
• 1yw2: Mutated Mus Musculus P38 Kinase (mP38)
  1yw2: Mutated Mus Musculus P38 Kinase (mP38)
• 1ywr: Crystal Structure Analysis of inactive P38 kinase domain in complex with a Monocyclic Pyrazolone Inhibitor
  1ywr: Crystal Structure Analysis of inactive P38 kinase domain in complex with a Monocyclic Pyrazolone Inhibitor
• 1zyj: Human P38 MAP Kinase in Complex with Inhibitor 1a
  1zyj: Human P38 MAP Kinase in Complex with Inhibitor 1a
• 1zz2: Two Classes of p38alpha MAP Kinase Inhibitors Having a Common Diphenylether Core but Exhibiting Divergent Binding Modes
  1zz2: Two Classes of p38alpha MAP Kinase Inhibitors Having a Common Diphenylether Core but Exhibiting Divergent Binding Modes
• 1zzl: Crystal structure of P38 with triazolopyridine
  1zzl: Crystal structure of P38 with triazolopyridine
• 2baj: p38alpha bound to pyrazolourea
  2baj: p38alpha bound to pyrazolourea
• 2bak: p38alpha MAP kinase bound to MPAQ
  2bak: p38alpha MAP kinase bound to MPAQ
• 2bal: p38alpha MAP kinase bound to pyrazoloamine
  2bal: p38alpha MAP kinase bound to pyrazoloamine
• 2baq: p38alpha bound to Ro3201195
  2baq: p38alpha bound to Ro3201195
• 2ewa: Dual binding mode of pyridinylimidazole to MAP kinase p38
  2ewa: Dual binding mode of pyridinylimidazole to MAP kinase p38
• 2fsl: mitogen activated protein kinase p38alpha (D176A+F327S) activating mutant form-A
  2fsl: mitogen activated protein kinase p38alpha (D176A+F327S) activating mutant form-A
• 2fsm: mitogen activated protein kinase p38alpha (D176A+F327S) activating mutant form-B
  2fsm: mitogen activated protein kinase p38alpha (D176A+F327S) activating mutant form-B
• 2fso: mitogen activated protein kinase p38alpha (D176A) activating mutant
  2fso: mitogen activated protein kinase p38alpha (D176A) activating mutant
• 2fst: mitogen activated protein kinase p38alpha (D176A+F327L) activating mutant
  2fst: mitogen activated protein kinase p38alpha (D176A+F327L) activating mutant
• 2gfs: P38 Kinase Crystal Structure in complex with RO3201195
  2gfs: P38 Kinase Crystal Structure in complex with RO3201195
• 2ghl: Mutant Mus Musculus P38 Kinase Domain in Complex with Inhibitor PG-874743
  2ghl: Mutant Mus Musculus P38 Kinase Domain in Complex with Inhibitor PG-874743
• 2ghm: Mutated MAP kinase P38 (Mus Musculus) in complex with Inhbitor PG-895449
  2ghm: Mutated MAP kinase P38 (Mus Musculus) in complex with Inhbitor PG-895449
• 2gtm: Mutated Mouse P38 MAP Kinase Domain in complex with Inhibitor PG-892579
  2gtm: Mutated Mouse P38 MAP Kinase Domain in complex with Inhibitor PG-892579
• 2gtn: Mutated MAP kinase P38 (Mus Musculus) in complex with Inhbitor PG-951717
  2gtn: Mutated MAP kinase P38 (Mus Musculus) in complex with Inhbitor PG-951717
• 2i0h: The structure of p38alpha in complex with an arylpyridazinone
  2i0h: The structure of p38alpha in complex with an arylpyridazinone
• 2okr: Crystal Structure of the P38a-MAPKAP kinase 2 Heterodimer
  2okr: Crystal Structure of the P38a-MAPKAP kinase 2 Heterodimer
• 2onl: Crystal Structure of the p38a-MAPKAP kinase 2 Heterodimer
  2onl: Crystal Structure of the p38a-MAPKAP kinase 2 Heterodimer
• 2oza: Structure of p38alpha complex
  2oza: Structure of p38alpha complex